SNAI2 and glioblastoma: However, EGFR amplification was clearly observed in 11.4% and 34.5% of scored SLUG+ (Figure 5C) and TAL1+ cells (Figure 5F), respectively, demonstrating that these two transcription factors can be expressed by some GBM tumoral cells.